Septum-guided Segmentectomy for 2-3 cm Clinical Stage IA3 Peripheral Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
- Status
- RECRUITING
- Phase
- PHASE3
Spatially Fractionated Radiotherapy With Tislelizumab and Chemotherapy for Bulky Stage III NSCLC: A Phase II Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult Participants
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
A Study of IOV-5001 in Adults With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Demographics, Clinical Characteristics and Outcomes in Resected Non-Small Cell Lung Cancer Patients Receiving Immunotherapy in Europe and Canada
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
LKB1 Expression and Clinical Outcomes in Non-Small Cell Lung Cancer: A Retrospective Cohort Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Nurse-Led Caregiver Support for Older Adults With Advanced Lung Cancer
- Status
- RECRUITING
- Phase
- NA
HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Segmentectomy Versus Lobectomy for Deep Solid-Dominant Early-Stage NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- NA
ctDNA-Guided Intraventricular Therapy for CNS Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Non-interventional, Real-world Study on the Adjuvant Treatment of Chinese EGFR-positive Stage IA NSCLC Patients With High-risk Factors Using Third-generation EGFR-TKIs.
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of SYS6010 Plus Anti-PD-(L)-1 Monoclonal Antibody as Adjuvant Therapy in Non-small Cell Lung Cancer (NSCLC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Evaluation of XYA02 in Patients With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for Squamous Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
ITTACA (Immunotherapy Time Teller for Advanced Lung Cancer)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A